AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

AA Aksyuk, H Bansal, D Wilkins, AM Stanley… - Cell Reports …, 2023 - cell.com
The nasal mucosa is an important initial site of host defense against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. However, intramuscularly administered …

2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare …

M Szapacs, W Jian, D Spellman, J Cunliffe… - Bioanalysis, 2023 - Taylor & Francis
Abstract The 16th Workshop on Recent Issues in Bioanalysis (16th WRIB) took place in
Atlanta, GA, USA on September 26–30, 2022. Over 1000 professionals representing …

Detailed Structural Elucidation of Antibody-Drug Conjugate Biotransformation Species Using High Resolution Multiple Reaction Monitoring Mass Spectrometry with …

J Yang, HY Tan, J Yuan, Y Huang… - ACS Pharmacology & …, 2024 - ACS Publications
Antibody-drug conjugates (ADCs) are a promising drug modality substantially expanding in
both the discovery space and clinical development. Assessing the biotransformation of …

Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) …

LE Clegg, O Stepanov, H Schmidt, W Tang… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
ABSTRACT AZD7442 is a combination of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)-neutralizing antibodies, tixagevimab and cilgavimab, developed for pre …

Bioanalytical method development for monoclonal antibodies: advances and challenges

SDM Kallam, A Bodapati, AS Reddy… - Cellular, Molecular and …, 2025 - cmbr-journal.com
Monoclonal antibodies (mAbs) represent a cornerstone of modern therapeutic strategies,
targeting a wide array of diseases with unprecedented specificity. Developing and validating …

Rapid Quantitation of Various Therapeutic Monoclonal Antibodies Using Membranes with Fc-Specific Ligands

J Yang, R Ostafe, CJ Welch, B Verhalen… - Analytical …, 2023 - ACS Publications
Therapeutic monoclonal antibodies (mAbs) provide effective treatments for many diseases,
including cancer, autoimmune disorders, and, lately, COVID-19. Monitoring the …

In-Membrane Enrichment and Peptic Digestion to Facilitate Analysis of Monoclonal Antibody Glycosylation

J Yang, R Ostafe, ML Bruening - Analytical Chemistry, 2024 - ACS Publications
The number of therapeutic monoclonal antibodies (mAbs) is growing rapidly due to their
widespread use for treating various diseases and health conditions. Assessing the …

Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitro IC50 values predict SARS‐CoV‐2 neutralising antibody titres

LE Clegg, O Stepanov, S Matthews… - Clinical & …, 2024 - Wiley Online Library
Objectives The evolution of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐
2) necessitates rapid methods for assessing monoclonal antibody (mAb) potency against …

Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry

G Martos, M Bedu, RD Josephs, S Westwood… - Analytical and …, 2024 - Springer
The availability of serology assays to measure antibodies against the SARS coronavirus 2
(SARS-CoV-2) expanded rapidly during the Covid-19 pandemic. The interchangeable use …

Exploring peptides from toad venom for source identification by LC-MS/MS using MRM method

L Zhu, J Xu, R Gan, D Xu, J Wang, J Zhou… - Journal of Pharmaceutical …, 2024 - Elsevier
Toad venom is a traditional Chinese medicine (TCM) with various sources and wide-ranging
preparations. Previous quality assessment studies primarily concentrated on small …